Novigenix | WebDisclosure

Basculer en Français

10700	Companies
228723	Keywords
157338	Articles
121406	Press releases

Home
Companies
Novigenix

PRESS RELEASE

published on 01/17/2024 at 08:00, 2 years 5 months ago

Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling
Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes.

Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care

Accesswire

Published on 07/08/2026 at 16:45, 2 hours 16 minutes ago

Change Of Record Date for Special Meeting
Published on 07/08/2026 at 15:25, 3 hours 36 minutes ago

Rockhaven Announces Granting of Incentive Stock Options
Published on 07/08/2026 at 15:00, 4 hours 1 minute ago

Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Published on 07/08/2026 at 15:00, 4 hours 1 minute ago

GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Published on 07/08/2026 at 14:30, 4 hours 31 minutes ago

Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily

View all ACCESSWIRE

EQS Group

Published on 07/08/2026 at 18:52, 8 minutes ago

namR: PRONONCÉ DE LA LIQUIDATION JUDICIAIRE DE LA SOCIÉTÉ SA NAM.R
Published on 07/08/2026 at 18:45, 16 minutes ago

EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
Published on 07/08/2026 at 18:17, 44 minutes ago

Dividend announcement
Published on 07/08/2026 at 18:16, 44 minutes ago

Kaufman & Broad SA: 2026 FIRST HALF RESULTS
Published on 07/08/2026 at 18:16, 44 minutes ago

Kaufman & Broad SA: RESULTATS DU 1ER SEMESTRE 2026

Les Echos

Published on 07/08/2026 at 18:30, 31 minutes ago

Suspension of the liquidity contract
Published on 07/08/2026 at 18:30, 31 minutes ago

Suspension du contrat de liquidité
Published on 07/08/2026 at 18:00, 1 hour 1 minute ago

464 M€ DE NOUVEAUX FINANCEMENTS POUR SOUTENIR LA CROISSANCE DE FREY
Published on 07/08/2026 at 18:00, 1 hour 1 minute ago

€464 MILLION OF NEW FINANCING TO SUPPORT FREY'S GROWTH
Published on 07/08/2026 at 17:45, 1 hour 16 minutes ago

Déclaration des droits de vote à fin juin 2026

View all LES ECHOS COMFI WIRE